Isoptin Rr (Verapamil Hydrochloride)

Isoptin Rr, a calcium channel blocker, is used in several cardiovascular conditions.

• Hypertension: lowers elevated blood pressure by reducing peripheral vascular resistance.
• Angina pectoris: relieves chest pain by decreasing myocardial oxygen demand through vasodilation.
• Cardiac arrhythmias (e.g., supraventricular tachycardia): restores normal rhythm by slowing conduction through the atrioventricular node.

• Verapamil Hydrochloride blocks L‑type calcium channels in cardiac and vascular smooth muscle cells, reducing intracellular calcium influx. This action diminishes myocardial contractility, slows atrioventricular nodal conduction, and promotes vasodilation of arterial smooth muscle, collectively lowering blood pressure and alleviating angina while stabilizing abnormal heart rhythms.

Adverse reactions may occur with verapamil therapy.

Common Side Effects

• Constipation: reduced gastrointestinal motility.
• Dizziness or light‑headedness: related to blood pressure changes.
• Headache: often mild and transient.
• Peripheral edema: swelling of lower extremities.
• Nausea: mild gastrointestinal upset.
• Fatigue: general feeling of tiredness.

Serious or Rare Side Effects

• Bradycardia: markedly slow heart rate.
• Severe hypotension: dangerous drop in blood pressure.
• AV block or other conduction disturbances.
• Allergic reactions: rash, itching, or anaphylaxis.
• Hepatic dysfunction: elevated liver enzymes or jaundice.

Before initiating therapy, clinicians should evaluate patient-specific risk factors.

• Monitor blood pressure: ensure therapeutic reduction without excessive hypotension.
• Assess cardiac function: especially in patients with existing heart failure or conduction abnormalities.
• Use caution in severe heart failure: verapamil may worsen symptoms.
• Avoid abrupt discontinuation: taper to prevent rebound hypertension.
• Review concomitant medications: check for potential interactions.
• Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Verapamil may interact with several medicines, requiring careful management.

Major Interactions (Avoid)

• Beta‑blockers: combined effect can cause profound bradycardia.
• Digoxin: increased serum levels may lead to toxicity.
• Diltiazem: additive AV‑node depression.
• Strong CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): elevate verapamil concentrations.

Moderate Interactions (Monitor Closely)

• Diuretics: may cause electrolyte imbalances, especially potassium.
• NSAIDs: can attenuate antihypertensive effect.
• Statins metabolized by CYP3A4 (e.g., simvastatin): monitor for increased statin levels.
• Antacids containing aluminum or magnesium: may reduce oral absorption of verapamil.